🔗 Share this article

An underground market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these profiles privately for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where groups with numerous of participants share comparison photos, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to users administering substances of unknown origin.

Some experts said the popularity for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, advertising, and customer regulations, risking penalties, legal action or imprisonment.

Service Response and Material Elimination

Based on TikTok, the platform has removed violative content and prohibited related keywords and search suggestions. The organization stated it was committed to maintaining the platform secure and investing in enhancing compliance measures.

Digital Trading Activities

Research also found communities with up to nine thousand members marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, positive reviews and detailed instructions for preparing or administering at residence.

Within moments of entering one community, a vendor shared WhatsApp details, where most transactions occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.

Item Information and Pricing

Within these groups, posts display dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors usually sold at £160 for 20mg. When asked how long a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for Telegram said it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they cannot confirm. Although the research behind this drug is sound, these online products may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously seen individuals injured by personal administration from unverified suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may subject users to possibly significant health risks”.